JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (2): 138-141.doi: 10.3969/j.issn.1005-6483.2022.02.012

Previous Articles     Next Articles

Clinical significance of POU3F2 expression in glioma

  

  1. Department of Neurosurgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030, China
  • Received:2021-12-23 Accepted:2021-12-23 Online:2022-02-20 Published:2022-02-20

Abstract: Objective To explore the expression and significance of POU3F2 in glioma based on the Chinese Glioma Genome Atlas(CGGA). Methods Based on CGGA,GEPIA2,String,Metascape and other databases,we analyze the differences in the expression of POU3F2 gene in different WHO grade groups of glioma with R program language.Meanwhile,IHC staining was conducted to detect the protein expression level of POU3F2 in collected glioma tumor tissues.Then the relationships between POU3F2 gene expression and molecular subtypes of glioma,molecular biomarkers and clinical prognosis were analyzed. Results The expression of POU3F2 was increased in the high grade glioma group(P=0.0037).Immunohistochemistry indicated that POU3F2 expression was also up-regulated in high grade glioma group (P<0.001).The expression levels of POU3F2 was the highest in the classical glioma,and the difference was significant between other molecular subtypes (all P<0.001),and the AUC value of POU3F2 predicted the classical glioma was 0.784.The expression levels of POU3F2 gene were significantly lower in glioma with chromosome 1p19q co-deletion.High levels of POU3F2 expression tended to have a poorer prognosis(P=0.013)and was verified in the TCGA database(P=0.0055).Conclusion The increased expression level of POU3F2 is associated with malignant glioma phenotype,and might be a molecular biomarker of glioma.

Key words: POU3F2, glioma, transcriptome, molecular biomarker, bioinformatics

[1] DAI Jiajing, HAN Xinle, ZHONG Fubo, et al.. Screening and bioinformatics of differential expression of circular RNAs in triple negative breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(3): 227-230.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] SHI Qiao, LIU Lei, ZHANG Xiaoyi, et al.. Meta-analysis:clinical efficacy of gemcitabine combination with high intensity focused ultrasound in the treatment of advanced pancreatic carcinoma in China[J]. JOURNAL OF CLINICAL SURGERY, 2019, 27(8): 680 -683 .
[2] ZHANG Ying, ZHANG Yan, WANG Jingjing.. A Meta analysis of preoperative fasting and water deprivation in selective surgical patients[J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(2): 151 -154 .
[3] XU Zhiliang, TAN Lingzhen, XUN Shengrong, et al.. Application of three kinds of parathyroid autotransplantation in thyroid cancer operation[J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(3): 228 -230 .
[4] LIANG Qingzhuang, LI Peng, XU Lu, et al. Experience in diagnosis and treatment of pulmonary changes and fever after extensive radical surgery for thyroid cancer[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(1): 68 -70 .
[5] ZHANG Zhenwei, SUN Jiahe, ZHANG Ligong, et al.. Analysis of risk factors and prognosis of patients with bone metastasis from breast cancer[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(3): 243 -247 .
[6] ZHENG Yuan, CHEN Bo.. Retrospective analysis of clinicopathological features of invasive ductal carcinoma with ductal carcinoma in situ[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1047 -1049 .
[7] ZHANG Peng, ZENG Xiangyu, TAO Kaixiong..

Updated interpretation of the U.S. national comprehensive cancer network guidelines for the diagnosis and treatment of gastrointestinal stromal tumors(2021.V1) [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 13 -16 .

[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 101 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 101 -104 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 105 -108 .